Atraumatic splenic rupture secondary to granulocyte-colony stimulating factor medication exposure

被引:0
作者
Daniel, Jeannez A. [1 ,3 ]
Roth, Kevin R. [1 ]
V. Patel, Priyal [2 ]
Schultz, Kristine L. [1 ]
机构
[1] Univ S Florida, Lehigh Valley Hlth Network, Morsani Coll Med, Dept Emergency & Hosp Med, Lehigh Valley Campus, Allentown, PA USA
[2] Univ S Florida, Inst Surg Excellence, Div Trauma Surg, Lehigh Valley Hlth Network,Morsani Coll Med, Lehigh Valley Campus, Allentown, PA USA
[3] LVHN M South 5th Floor,2545 Schoenersville Rd, Bethlehem, PA 18017 USA
关键词
Splenic rupture; Atraumatic; G-CSF; Marrow donation; Filgrastim;
D O I
10.1016/j.ajem.2024.04.036
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Hematopoietic hormones such as granulocyte -colony stimulating factors are commonly used prevent neutropenia in patients undergoing chemotherapy and to prepare patients for bone marrow donations. In rare cases, splenic injury can result from exposure to this medication. We present the case of a 30 -year -old man who presented to the emergency department the day after a bone marrow donation procedure complaining of severe, acute onset left upper quadrant abdominal pain, radiating to the shoulder. Neither the patient nor his family reported any abdominal trauma prior to or following the marrow donation procedure. An initial bedside ultrasound examination was positive for peritoneal fluid and distortion of the normal splenic architecture, raising suspicion for possible intraabdominal or splenic injury. An emergent con firmatory CT with contrast of the abdomen confirmed the initial ultrasound examination suspicion of an atraumatic splenic rupture and with evidence of venous bleeding but without active arterial extravasation. An emergent trauma surgery consultation was placed, and he underwent embolization with an uneventful recovery. This case report highlights the need for a high index of suspicion for atraumatic splenic rupture in patients exposed to these types of granulocyte -colony stimulating factors. (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页码:228.e1 / 228.e4
页数:4
相关论文
共 50 条
  • [11] Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
    Ashrafi, Farzaneh
    Salmasi, Mehrzad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
  • [12] Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: Which to choose?
    Elfenbein, GJ
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 37 - 47
  • [13] Granulocyte-colony stimulating factor: a new player for the enteric nervous system
    Schuster, Anne
    Klotz, Markus
    Schwab, Tanja
    Lilischkis, Rainer
    Schneider, Armin
    Schaefer, Karl-Herbert
    CELL AND TISSUE RESEARCH, 2014, 355 (01) : 35 - 48
  • [14] New treatment with granulocyte-colony stimulating factor in diabetic foot ulceration
    Kreyden, OP
    Hafner, J
    Burg, G
    Nestle, FO
    HAUTARZT, 2001, 52 (04): : 327 - 330
  • [15] The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats
    Matchett, Gerald A.
    Calinisan, Jason B.
    Matchett, Genoveve C.
    Martin, Robert D.
    Zhang, John H.
    BRAIN RESEARCH, 2007, 1136 (01) : 200 - 207
  • [16] Granulocyte-Colony Stimulating Factor as Treatment Option in Patients with Recurrent Miscarriage
    Claudia Santjohanser
    Catherine Knieper
    Cordula Franz
    Kaino Hirv
    Osama Meri
    Manfred Schleyer
    Wolfgang Würfel
    Bettina Toth
    Archivum Immunologiae et Therapiae Experimentalis, 2013, 61 : 159 - 164
  • [17] Granulocyte-Colony Stimulating Factor as Treatment Option in Patients with Recurrent Miscarriage
    Santjohanser, Claudia
    Knieper, Catherine
    Franz, Cordula
    Hirv, Kaino
    Meri, Osama
    Schleyer, Manfred
    Wuerfel, Wolfgang
    Toth, Bettina
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2013, 61 (02) : 159 - 164
  • [18] Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells
    Uemura, Y
    Kobayashi, M
    Nakata, H
    Harada, R
    Kubota, T
    Taguchi, H
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (06) : 826 - 832
  • [19] Nanoparticles decorated with granulocyte-colony stimulating factor for targeting myeloid cells
    Margulis, Katherine
    Honkala, Alexander
    Kalashnikova, Irina
    Noll, Sarah E.
    Hill, Meghan
    Zare, Richard N.
    Smith, Bryan Ronain
    NANOSCALE, 2020, 12 (04) : 2752 - 2763
  • [20] Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease
    Meuer, K
    Pitzer, C
    Teismann, P
    Krüger, C
    Göricke, B
    Laage, R
    Lingor, P
    Peters, K
    Schlachetzki, JCM
    Kobayashi, K
    Dietz, GPH
    Weber, D
    Ferger, B
    Schäbitz, WR
    Bach, A
    Schulz, JB
    Bähr, M
    Schneider, A
    Weishaupt, JH
    JOURNAL OF NEUROCHEMISTRY, 2006, 97 (03) : 675 - 686